280.10 -0.02 (-0.01%)
After hours: 4:16PM EST
|Bid||263.90 x 800|
|Ask||285.37 x 100|
|Day's Range||275.76 - 283.91|
|52 Week Range||215.52 - 290.84|
|Beta (3Y Monthly)||1.08|
|PE Ratio (TTM)||16.23|
|Earnings Date||Jan 30, 2019|
|Forward Dividend & Yield||3.00 (1.05%)|
|1y Target Est||318.84|
NEW YORK, Nov. 14, 2018 -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Anthem, Inc. (NYSE: ANTM). On July 24,.
Given this chart and analysis, my trading strategy is to buy Aetna shares on weakness to annual value level of $161.49 and reduce holdings on strength to my quarterly risky level at $218.10. Given this chart and analysis, traders should buy Anthem shares on weakness to my annual value level of $194.00 and reduce holdings on strength to my quarterly risky level at $300.91. Given this chart and analysis, I suggest buying Humana shares on weakness to my annual value level of $253.11 and reducing holdings on strength to my quarterly risky level at $353.33, which was tested after the election on Nov. 7.
Humana earnings, the Democratic House takeover and Medicaid expansions in 3 states sent health insurers soaring Wednesday. Humana and several peers hit buy points.
Anthem (ANTM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Anthem, Inc. (ANTM) announced today that senior management is scheduled to present at the Credit Suisse 27th Annual Healthcare Conference on November 14, 2018, at 12:20 p.m. Eastern Standard Time (EST). Anthem is working to transform health care with trusted and caring solutions.
SAN DIEGO, CA / ACCESSWIRE / November 6, 2018 / The Shareholders Foundation, Inc. announces that a lawsuit was filed by a current investor in shares of Anthem, Inc. (NYSE: ANTM) over alleged breaches of ...
The company also reported higher-than-expected third quarter profit as it reined in costs. "We're entering 2019 in a position of strength," Chief Executive Officer Gail Boudreaux said on a conference call with analysts. Current 2019 consensus estimates for core earnings are "slightly below" Anthem's long-term high-single to low-double digit growth target, she added.
Inc.’s earnings climbed in the third quarter and the health insurer boosted its earnings guidance for the year. Analysts polled by Refinitiv were expecting earnings of $3.50 a share. Analysts polled by Refinitiv were expecting $22.94 billion.
Dividends can be underrated but they form a large part of investment returns, playing an important role in compounding returns in the long run. Historically, Anthem Inc (NYSE:ANTM) has been Read More...
Investing.com - Anthem (NYSE:ANTM) reported third quarter earnings that beat analyst's expectations on Wednesday and revenue that topped forecasts.
Anthem (ANTM) delivered earnings and revenue surprises of 3.81% and 0.32%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Anthem Inc reported quarterly profit that topped analysts' estimates on Wednesday on lower medical costs and the No.2 U.S. health insurer raised its full-year adjusted earnings forecast. Anthem's benefit expense ratio - an insurer's spending on claims against the premiums it earns - improved to 84.8 percent from 87 percent in the year-ago period, as it kept a tight lid on costs from its commercial health plans. The health insurer said it now expected full-year adjusted earnings forecast to be more than $15.60 per share, up from the prior forecast of over $15.40 per share.
The Indianapolis-based company said it had profit of $3.62 per share. Earnings, adjusted for one-time gains and costs, were $3.81 per share. The results topped Wall Street expectations. The average estimate ...
Anthem Inc reported a 28.5 percent rise in quarterly profit on Wednesday, as the U.S. health insurer reined in medical costs. Net income rose to $960 million, or $3.62 per share, in the third quarter ended ...